Christopher J Sobecki Net Worth & Insider Trades
Christopher J Sobecki - Director, Lexicon Pharmaceuticals, Inc
What is Christopher J Sobecki's Net Worth?
The current estimated net worth of Lexicon Pharmaceuticals, Inc's Director, Christopher J Sobecki, is estimated to be about $575.61K . Christopher J Sobecki owns about 137,293 units of Lexicon Pharmaceuticals, Inc common stock. In the last 13 years at Lexicon Pharmaceuticals, Inc, Christopher J Sobecki has sold an estimated value of $0 worth.
What is Christopher J Sobecki's Past Insider Trading?
Christopher J Sobecki's largest purchase order was 99,249 units , worth over $238.75K on September 17, 2019. In total, Christopher J Sobecki has made about 19 transactions over 13 years of their time at Lexicon Pharmaceuticals, Inc. Christopher J Sobecki usually trades in April, with the busiest year in 2019. The most recent transaction was a purchase order of 25,000 units , worth over $63.72K on September 17, 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Christopher J Sobecki
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Christopher J Sobecki's' Mailing Address?
- Mailing address is C/o WW International 675 Avenue of the Americas, 6th Floor New York NY 10010 NY
What are Lexicon Pharmaceuticals, Inc's Past Insider Trades?
Lexicon Pharmaceuticals, Inc's most recent insider trade came on September 14, 2023 by Jeffrey L Wade who bought 10,000 units worth $13.8K . In the last 16 years, insiders at Lexicon Pharmaceuticals, Inc have sold an estimated value of $4.48M and bought an estimated value of $859.9M worth of shares. Insider trading is most common in February, with the busiest year in 2023. The most active traders at the company are Jeffrey L Wade, President and CFO, Raymond Debbane, Director, and Alan J Main, EVP .
LEXICON PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |